YAP Transcriptional Activity Dictates Cell Response to TNF


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 16 01 2022
accepted: 23 02 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 13 4 2022
Statut: epublish

Résumé

YAP/TAZ are transcription co-factors recently described responsive to pro-inflammatory cytokines and involved in inflammatory-related disorders. However, the role of tumor necrosis factor (TNF), a major pro-inflammatory cytokine, on YAP signaling is not well understood and controversial. Here, we observe

Identifiants

pubmed: 35401557
doi: 10.3389/fimmu.2022.856247
pmc: PMC8989468
doi:

Substances chimiques

NF-kappa B 0
Transcription Factors 0
Tumor Necrosis Factor-alpha 0
YAP-Signaling Proteins 0
YAP1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

856247

Informations de copyright

Copyright © 2022 Caire, Dalix, Chafchafi, Thomas, Linossier, Normand, Guignandon, Vico and Marotte.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nature. 2015 Mar 5;519(7541):57-62
pubmed: 25731159
J Cell Physiol. 2018 Mar;233(3):2409-2419
pubmed: 28731277
Genes Dev. 2001 May 15;15(10):1229-41
pubmed: 11358867
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Nat Rev Cancer. 2015 Feb;15(2):73-79
pubmed: 25592648
J Pathol. 2008 Jan;214(2):149-60
pubmed: 18161752
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
J Biol Chem. 2007 Jun 15;282(24):17450-9
pubmed: 17438336
Front Immunol. 2021 Dec 09;12:791907
pubmed: 34956224
Mol Med. 1999 Jun;5(6):382-92
pubmed: 10415163
Cell. 2014 Jul 3;158(1):157-70
pubmed: 24976009
J Biol Chem. 2021 Jan-Jun;296:100400
pubmed: 33571521
Nat Cell Biol. 2015 Sep;17(9):1218-27
pubmed: 26258633
Int J Mol Sci. 2018 Nov 01;19(11):
pubmed: 30388809
Cell. 1996 Jan 26;84(2):299-308
pubmed: 8565075
Thromb Haemost. 2014 Dec;112(6):1088-102
pubmed: 25078148
Cell. 2012 Aug 17;150(4):780-91
pubmed: 22863277
Cell Rep. 2020 Aug 4;32(5):107990
pubmed: 32755583
Mol Med. 2019 Jul 12;25(1):32
pubmed: 31299894
Biochem Pharmacol. 2016 Sep 15;116:1-10
pubmed: 26993379
Nat Rev Nephrol. 2016 Jun;12(6):325-38
pubmed: 27108839
Arthritis Res Ther. 2014 Apr 24;16(2):R102
pubmed: 24762050
Nat Commun. 2018 Nov 1;9(1):4564
pubmed: 30385786
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2270-5
pubmed: 21262812
Nature. 2016 Dec 07;540(7634):579-582
pubmed: 27926730
Nat Rev Rheumatol. 2013 Jan;9(1):24-33
pubmed: 23147896
Cell. 2013 Aug 29;154(5):1047-1059
pubmed: 23954413
Nat Commun. 2018 Jul 27;9(1):2961
pubmed: 30054475
Nat Cell Biol. 2016 Feb;18(2):168-80
pubmed: 26689676
Clin Cancer Res. 2018 Apr 15;24(8):2015-2025
pubmed: 29437787
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Nat Commun. 2017 May 15;8:15321
pubmed: 28504269
J Am Soc Nephrol. 2016 Oct;27(10):3117-3128
pubmed: 26961347
Circ Res. 2018 Jun 22;123(1):43-56
pubmed: 29794022
J Biol Chem. 2010 Nov 26;285(48):37159-69
pubmed: 20858893
Cell. 2007 Sep 21;130(6):1120-33
pubmed: 17889654
Oncogene. 2002 Jul 18;21(31):4728-38
pubmed: 12101411
Cell. 2003 Jul 25;114(2):181-90
pubmed: 12887920
Drug Dev Res. 2015 Dec;76(8):419-27
pubmed: 26482111
Annu Rev Cell Dev Biol. 2005;21:247-69
pubmed: 16212495
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Mol Biol Cell. 2014 May;25(10):1676-85
pubmed: 24648494
Hepatology. 2018 Feb;67(2):736-749
pubmed: 28902427
Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii23-8
pubmed: 17934089
Front Immunol. 2020 Oct 06;11:587913
pubmed: 33123172
Genes Dev. 2008 Jul 15;22(14):1962-71
pubmed: 18579750
Front Biosci. 2006 Jan 01;11:529-43
pubmed: 16146751
Mol Cancer Res. 2012 Aug;10(8):1109-19
pubmed: 22707636
Oncogenesis. 2017 Sep 25;6(9):e383
pubmed: 28945218
Development. 2016 May 15;143(10):1674-87
pubmed: 26989177
Nat Rev Cancer. 2009 May;9(5):361-71
pubmed: 19343034
Gut. 2018 Sep;67(9):1692-1703
pubmed: 28866620

Auteurs

Robin Caire (R)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Elisa Dalix (E)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Marwa Chafchafi (M)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Mireille Thomas (M)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Marie-Thérèse Linossier (MT)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Myriam Normand (M)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Alain Guignandon (A)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Laurence Vico (L)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.

Hubert Marotte (H)

INSERM, U1059-SAINBIOSE, Université de Lyon, Saint-Etienne, France.
Department of Rheumatology, Hôpital Nord, University Hospital Saint-Etienne, Saint-Etienne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH